Research Studies

Interested in participating in research studies? Scroll down to browse our current list.

Drug

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Assess the Efficacy and Safety of JNJ-63733657, an Anti-tau Monoclonal Antibody, in Participants with Early Alzheimer's Disease

Drug

A Phase 3, multi-center, randomized, double-blind, parallel-group, placebo-controlled clinical trial to evaluate the efficacy and safety of sodium oligomannate (GV-971) in treatment of mild to moderate Alzheimer's disease (GREEN MEMORY: GREen Valley 971 E

Drug

Escitalopram for Agitation in Alzheimer's Disease (S-citAD) Study at Ontario Shores

Participate in Research through MINT Memory Clinic

Questions about MINT Clinic Research Match?

Contact us